While GLP-1 and GLP-1/GIP medications are generally considered cost-effective for treating obesity in targeted populations [65,66,67], alternative strategiessuch as expanding bariatric surgery access, enhancing lifestyle intervention programmes, pharmaceutical management of cardiometabolic comorbidities, or population-level policiesshould also be considered
Explained simply and clearly in this short video
As Seen On Schedule Your Consultation Today
What is Glutathione and Why Do Pakistanis Use It
Reactive oxygen species (ROS) in cancer pathogenesis and therapy: an update on the role of ROS in anticancer action of benzophenanthridine alkaloids
Since the burning of fat is a major source of muscular energy, deficiencies in L-Carnitine are manifested as low energy levels and muscular weakness